A dinuclear palladium complex haVing bridging diphenylgermyl ligands, [{Pd(PCy 3 )} 2 (µ-HGePh 2 ) 2 ] (1), was obtained from the reaction of Ph 2 GeH 2 with [Pd(PCy 3 ) 2 ]. X-ray crystallographic results and NMR spectra of 1 reVealed coordination of the Ge ligands to two Pd centers Via a Ge-H-Pd three-center-two-electron bond and a Ge-Pd σ bond. The reaction of Ph 2 GeH 2 with [Pt(PCy 3 ) 2 ] produces the (germyl)hydridoplatinum complexes cis-[Pt(H)(GeHPh 2 )(PCy 3 ) 2 ] (cis-3) and trans-[Pt(H)(GeHPh 2 )(PCy 3 ) 2 ] (trans-3) as the kinetic and thermodynamic products, respectiVely.
A complex with a planar hexagonal Pd(4)Ge(3) core, [Pd{Pd(dmpe)}(3)(μ(3)-GePh(2))(3)], was synthesized and characterized by X-ray and NMR measurements as well as by DFT calculations. 4-tert-Butylbenzenethiol converted the Pd(4) complex into a hexapalladium complex, [{Pd(3)(μ-GePh(2))(2)(μ-H)(μ(3)-GePh(2)(SC(6)H(4)(t)Bu-4))}(2)(μ-dmpe)], composed of two Pd(3)Ge(3) units bridged by a dmpe ligand. The addition of CuI or AgI to the Pd(4) complex yielded [Pd(μ-MI){Pd(dmpe)}(3)(μ(3)-GePh(2))(3) ] (M = Cu, Ag), in which Cu or Ag bridges a Pd-Pd bond of the Pd(4)Ge(3) core. The CuI adducts in solution undergo a pivot motion of the CuI on the surface of the Pd(4)Ge(3) plane on the NMR time scale.
Heating a toluene solution of bis(germyl)palladium complex [Pd(GeHPh2)2(dmpe)] (2) (dmpe = 1,2-bis(dimethylphosphino)ethane) at 70 °C produced a mixture of dipalladium complexes, one with bridging digermene and germylene ligands, [{Pd(dmpe)}2(μ-GePh2)(μ-Ge2Ph4)] (3), and also a mononuclear tetragermapalladacyclopentane, [Pd(GePh2GePh2GePh2
GePh2)(dmpe)] (4), in 92:8 molar ratio, respectively. The reaction of H2GePh2 with 2 in 10:1 molar ratio formed complex 4 as the main product (3:4 = 4:96). Complexes 3 and 4 were isolated from the above reactions and characterized by X-ray crystallography and NMR spectroscopy. Complex 3 reacted with H2GePh2 (Pd:Ge = 1:10) at 80 °C to yield 4 quantitatively, whereas simple heating of 3 at the same temperature did not form 4 at all. Reaction pathways for the Ge−Ge bond formation are discussed.
The dinuclear palladium(I) complexes [L(Ar2 HGe)Pd(μ-GeAr2 )2 Pd(GeHAr2 )L] (Ar=Ph, p-Tol; L=PMe3 , tBuNC) contain terminal germyl and bridging germylene ligands with the experimentally observed Ge⋅⋅⋅Ge bond lengths of 2.8263(4) Å (L=PMe3 ) and 2.928(1) Å (L=tBuNC), which are close to the longest Ge-Ge bond reported to date [2.714(1) Å]. Significant Ge⋅⋅⋅Ge interactions between the germylene and germyl ligands (PMe3 complexes > tBuNC complexes) are supported by DFT calculations, Wiberg bond indices (WBI), and natural bond orbital (NBO) analyses. Exchanging tBuNC for PMe3 ligands increases the Ge⋅⋅⋅Ge interaction, and simultaneously activates two Pd-Ge bonds. Adding the chelating diphosphine 1,2-bis(diethylphosphino)ethane (depe) to the PMe3 complexes results in the intramolecular coupling of germyl and germylene ligands followed by extrusion of a digermane.
The bis(germyl)platinum complex [Pt(GeHPh2)2(dmpe)] (1) (dmpe = 1,2-bis(dimethylphosphino)ethane) reacts with a small excess of H2GePh2 at 90 °C to produce four-membered germaplatinacycle [Pt(GePh2GePh2
GePh2)(dmpe)] (2). Further reaction of 2 with excess H2GePh2 at 90 °C forms tetragermaplatinacyclopentane [Pt(GePh2GePh2GePh2
GePh2)(dmpe)] (3), while 3 is obtained also by the direct reaction of excess H2GePh2 with 1 for a prolonged period. Complexes 1−3 were characterized by X-ray crystallography and NMR spectroscopy. Germaplatinacycles 2 and 3 react with H3GePh to cause cleavage of the Pt−Ge bonds and formation of the oligogermanes H(GePh2)3H and H(GePh2)4H, respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.